This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Lucrece Nicoud, PhD
Co-CEO at Ypso-Facto
Speaker

Profile

Lucrèce is a (bio)chemical engineer with expertise in process modeling and separation science. She graduated from ENSIC (Nancy, France) with major in chemical engineering and obtained her PhD from the ETH Zurich (Switzerland) in 2015. Her doctoral work focused on the stability of therapeutic proteins. As a post-doctoral fellow at ETH Zurich, she worked on the modeling of chromatographic systems, both single and multicolumn. She also contributed to the book Continuous Biopharmaceutical Processes: Chromatography, Bioconjugation and Protein Stability. Then, she carried out a research project at MIT (Cambridge, MA, USA) in the field of pharmaceuticals crystallization. She joined Ypso-Facto in 2018, that she is currently leading after being involved both in scientific consulting and software development.

Agenda Sessions

  • How Mechanistic Modeling Can Alleviate Challenges from Process Development to Scale-up of Oligonucleotides

    11:30